GZMB and ovarian cancer: Hsp22 correlated with Granzyme B in all three groups: ovarian cancer (tau = 0.7, p = 0.0007), endometrial cancer (tau = 0.6, p = 0.003), endometriosis (tau = 0.8, p = 0.001).